PMID- 32713757
OWN - NLM
STAT- MEDLINE
DCOM- 20210818
LR  - 20210818
IS  - 2211-5684 (Electronic)
IS  - 2211-5684 (Linking)
VI  - 101
IP  - 11
DP  - 2020 Nov
TI  - Image-guided core biopsy of 2-cm or smaller renal tumors.
PG  - 715-720
LID - S2211-5684(20)30186-8 [pii]
LID - 10.1016/j.diii.2020.07.002 [doi]
AB  - PURPOSE: The purpose of this study was to retrospectively evaluate diagnostic 
      yield, risk factors for diagnostic failure, and safety of image-guided core 
      biopsy of renal tumors</=2cm. MATERIALS AND METHODS: Eighty-four biopsies of 84 
      renal tumors (mean size, 1.5+/-0.4[SD] cm; range, 0.6-2.0cm) from 84 patients (53 
      men, 31 women; mean age, 61.7+/-12.7 [SD] years; age range, 34-87 years) were 
      included. All adverse events (AEs) were evaluated based on the CIRSE 
      classification. The 84 procedures were classified as diagnostic or nondiagnostic. 
      Multiple variables related to the patients, tumors, and procedures were assessed 
      to identify variables associated with diagnostic failure. RESULTS: All 84 
      biopsies (100%) were technically successful, defined as penetration of the target 
      and acquisition of some specimens. Eighty (80/84; 95.2%) biopsy procedures were 
      diagnostic and four (4/84; 4.8%) procedures were nondiagnostic. Among 80 
      diagnosed renal tumors, 71/80 (88.8%) tumors were malignant (49 clear cell renal 
      cell carcinomas [RCCs], 14 papillary RCCs, 3 chromophobe RCCs, 3 metastatic renal 
      cancers, 1 lymphoma, and 1 unclassified RCC) and 9/80 (11.2%) lesions were benign 
      (5 angiomyolipomas, 3 oncocytomas, and 1 inflammatory lesion). No significant 
      differences existed in any variables between the two groups. A total of 57 
      (57/84; 67.9%) procedures resulted in 56 Grade 1, 2 Grade 2, and 1 Grade 3 AEs. 
      CONCLUSION: Image-guided biopsy of renal tumors</=2cm is safe and has a high 
      diagnostic yield.
CI  - Copyright (c) 2020 Societe francaise de radiologie. Published by Elsevier Masson 
      SAS. All rights reserved.
FAU - Iguchi, T
AU  - Iguchi T
AD  - Department of Radiology, Okayama University Medical School, 2-5-1 Shikata-cho 
      kita-ku, Okayama 700-8558, Japan. Electronic address: iguchi@ba2.so-net.ne.jp.
FAU - Hiraki, T
AU  - Hiraki T
AD  - Department of Radiology, Okayama University Medical School, 2-5-1 Shikata-cho 
      kita-ku, Okayama 700-8558, Japan.
FAU - Matsui, Y
AU  - Matsui Y
AD  - Department of Radiology, Okayama University Medical School, 2-5-1 Shikata-cho 
      kita-ku, Okayama 700-8558, Japan.
FAU - Tomita, K
AU  - Tomita K
AD  - Department of Radiology, Okayama University Medical School, 2-5-1 Shikata-cho 
      kita-ku, Okayama 700-8558, Japan.
FAU - Uka, M
AU  - Uka M
AD  - Department of Radiology, Okayama University Medical School, 2-5-1 Shikata-cho 
      kita-ku, Okayama 700-8558, Japan.
FAU - Tanaka, T
AU  - Tanaka T
AD  - Department of Radiology, Okayama University Medical School, 2-5-1 Shikata-cho 
      kita-ku, Okayama 700-8558, Japan.
FAU - Komaki, T
AU  - Komaki T
AD  - Department of Radiology, Okayama University Medical School, 2-5-1 Shikata-cho 
      kita-ku, Okayama 700-8558, Japan.
FAU - Toji, T
AU  - Toji T
AD  - Department of Pathology, Okayama University Hospital, 2-5-1 Shikata-cho kita-ku, 
      Okayama 700-8558, Japan.
FAU - Gobara, H
AU  - Gobara H
AD  - Department of Radiology, Okayama University Medical School, 2-5-1 Shikata-cho 
      kita-ku, Okayama 700-8558, Japan.
FAU - Kanazawa, S
AU  - Kanazawa S
AD  - Department of Radiology, Okayama University Medical School, 2-5-1 Shikata-cho 
      kita-ku, Okayama 700-8558, Japan.
LA  - eng
PT  - Journal Article
DEP - 20200723
PL  - France
TA  - Diagn Interv Imaging
JT  - Diagnostic and interventional imaging
JID - 101568499
SB  - IM
MH  - *Adenoma, Oxyphilic/diagnostic imaging
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Biopsy
MH  - *Carcinoma, Renal Cell/diagnostic imaging
MH  - Female
MH  - Humans
MH  - Image-Guided Biopsy
MH  - *Kidney Neoplasms/diagnostic imaging
MH  - Male
MH  - Middle Aged
MH  - Retrospective Studies
OTO - NOTNLM
OT  - Biopsy
OT  - Kidney
OT  - Neoplasms
OT  - Percutaneous biopsy
OT  - Renal cell carcinoma
EDAT- 2020/07/28 06:00
MHDA- 2021/08/19 06:00
CRDT- 2020/07/28 06:00
PHST- 2020/06/03 00:00 [received]
PHST- 2020/07/04 00:00 [revised]
PHST- 2020/07/08 00:00 [accepted]
PHST- 2020/07/28 06:00 [pubmed]
PHST- 2021/08/19 06:00 [medline]
PHST- 2020/07/28 06:00 [entrez]
AID - S2211-5684(20)30186-8 [pii]
AID - 10.1016/j.diii.2020.07.002 [doi]
PST - ppublish
SO  - Diagn Interv Imaging. 2020 Nov;101(11):715-720. doi: 10.1016/j.diii.2020.07.002. 
      Epub 2020 Jul 23.